Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphoma

In this multicenter, single‐arm, phase II study, the efficacy and safety of ibrutinib were examined in Japanese patients with relapsed or refractory mantle cell lymphoma (MCL). Patients (age ≥20 years) with relapsed or refractory MCL who had progressed after receiving at least one prior treatment re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Maruyama, Dai, Nagai, Hirokazu, Fukuhara, Noriko, Kitano, Toshiyuki, Ishikawa, Takayuki, Shibayama, Hirohiko, Choi, Ilseung, Hatake, Kiyohiko, Uchida, Toshiki, Nishikori, Momoko, Kinoshita, Tomohiro, Matsuno, Yoshihiro, Nishikawa, Tomoaki, Takahara, Satoko, Tobinai, Kensei
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2016
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5198949/
https://ncbi.nlm.nih.gov/pubmed/27616553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13076
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados